News from Zyme and the companies we work with.
Mursla Bio collaborates with a leading global pharma company to advance biomarker-guided precision medicine in MASH
Mursla Bio’s AI Precision Medicine Platform to inform drug development and patient stratification in metabolic liver disease Cambridge, UK, and Boston MA, USA, 13 November 2025: Mursla Bio, a leader [...]
Shift Bioscience publishes improved metric calibration framework for robust genetic perturbation modeling using AI Virtual Cells
AI virtual cells outperform key baselines on well-calibrated metrics, challenging prior reports of poor model performance Foundational research reinforces the use of virtual cell models to accelerate target identification pipelines [...]
TRIMTECH Therapeutics appoints Dr Mike Hutton to Scientific Advisory Board
Industry leader brings deep expertise across neurodegenerative disease therapeutics development Dr Hutton joins Prof. Alessio Ciulli FRS and Dr Adam Gilbert on SAB Cambridge, UK, 11 November 2025: TRIMTECH Therapeutics, [...]
SPT Labtech and Alithea Genomics Collaborate to Automate Ultra Sensitive Single-Cell Transcriptomic Workflows
Integrates Alithea Genomics’ MERCURIUS FLASH-seq single-cell RNA-seq protocol with SPT Labtech’s firefly liquid handling platform Enables higher-throughput, cost efficient single-cell sequencing Cambridge, UK, and Lausanne, Switzerland, 05 November 2025: SPT [...]
Optibrium Delivers Real-Time Collaboration in its Comprehensive Molecular Design Platform with StarDrop 8
Latest release accelerates hit-to-candidate progression by keeping teams aligned, eliminating inefficiencies and enabling better prioritisation decisions CAMBRIDGE, UK, 04 November 2025 – Optibrium, a leading developer of software and AI [...]
Nuclera expands access to eProtein Discovery for APAC customers with distributor agreement in Australia and New Zealand
Partnership with Solve Scientific strengthens international sales as part of ongoing global expansion Cambridge, UK, and Boston MA, USA, 03 November 2025: Nuclera, the biotechnology company accelerating drug discovery by [...]
VALANX Biotech appoints Klaus Orlinger, PhD. as Chief Scientific Officer
Strategic hire of industry expert bolsters leadership team as Company progresses first antibody drug conjugate to candidate selection phase Appointment will drive development of VALANX’ GoldenSite™ platform to advance development [...]
ProImmune Ltd introduces ProVE® SL Self-Loading MHC Class I Monomers to improve T cell research flexibility
Oxford, UK – 30 October 2025 – ProImmune Ltd, a global leader in life science reagents and services, today announced the launch of its new ProVE® SL Self-Loading MHC Class [...]
Qureight Vascul8 model for pulmonary vascular disorders validated in peer-reviewed study, offering potential to improve treatment options and patient outcomes following surgery
Study published in ‘American Journal of Respiratory Cell and Molecular Biology’ validates Qureight’s deep-learning models and imaging platform beyond fibrotic lung disease, into new therapeutic areas for severe respiratory disease [...]
OMED Health Partners with Aviva to Support the Digestive Health of Employees
75 Aviva employees to gain pilot access to doctor-led OMED Health Plans, which include the use of the OMED Health Breath Analyzer and mobile app Collaboration will evaluate the impact [...]
Biodesix Announces Expanded Bio-Rad Laboratories Partnership Agreement to Develop Droplet Digital™ PCR High Complexity Assays
Biodesix will perform the clinical validation of ddPLEX ESR1 Mutation Detection Assay for advanced breast cancer testing LOUISVILLE, Colorado — October 22, 2025 — Biodesix, Inc. (NYSE: BDSX), a leading [...]
ProImmune Expands into New 18,000 sq ft Global Headquarters Enabling Major Expansion in Immunology and Life Science Innovation
Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UK Increased operational capacity enables accelerated development of ProImmune’s REVEAL® Immunogenicity [...]
